comparemela.com
Home
Live Updates
Chinas Tsingke Biotechnology secures $57m in Series B round : comparemela.com
China's Tsingke Biotechnology secures $57m in Series B round
The firm will use the proceeds to upgrade its technology platform as well as for team expansion.
Related Keywords
China
,
Henan
,
Zhongyuan
,
Jiangsu
,
Shenzhen
,
Guangdong
,
Qingsong
,
Jilin
,
Chinese
,
,
Huirong Fund Management
,
Shenzhen Investment Holding Capital
,
Henan Investment Group
,
Qingsong Fund
,
Yueyin Medical Fund
,
Tsingke Biotechnology
,
Fortune Capital
,
Fund Management
,
Zhongyuan Asset Management
,
Beijing Based Tsingke
,
Softbank China Venture Capital
,
Sharewin Capital
,
Greater China
,
comparemela.com © 2020. All Rights Reserved.